Pfizer Inc (PFE)
Return on assets (ROA)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 8,014,000 | 4,260,000 | -2,599,000 | -296,000 | 2,132,000 | 10,470,000 | 21,472,000 | 29,051,000 | 31,372,000 | 29,771,000 | 29,309,000 | 24,966,000 | 21,979,000 | 19,180,000 | 13,228,000 | 11,154,000 | 9,632,000 | 8,701,000 | 14,187,000 | 15,744,000 |
| Total assets | US$ in thousands | 213,396,000 | 219,476,000 | 216,193,000 | 221,095,000 | 226,501,000 | 215,021,000 | 220,168,000 | 195,617,000 | 197,206,000 | 195,349,000 | 195,290,000 | 183,841,000 | 181,477,000 | 179,188,000 | 169,920,000 | 158,818,000 | 154,229,000 | 178,983,000 | 177,934,000 | 166,336,000 |
| ROA | 3.76% | 1.94% | -1.20% | -0.13% | 0.94% | 4.87% | 9.75% | 14.85% | 15.91% | 15.24% | 15.01% | 13.58% | 12.11% | 10.70% | 7.78% | 7.02% | 6.25% | 4.86% | 7.97% | 9.47% |
December 31, 2024 calculation
ROA = Net income (ttm) ÷ Total assets
= $8,014,000K ÷ $213,396,000K
= 3.76%
Pfizer Inc's return on assets (ROA) has shown fluctuating trends over the reviewed periods. The ROA increased steadily from 9.47% as of March 31, 2020, to peak at 15.91% by December 31, 2022. However, from March 31, 2023, the ROA started declining, reaching a negative value of -1.20% by June 30, 2024.
Overall, Pfizer Inc's ROA performance indicates periods of strong profitability in the earlier years, followed by a significant decline in profitability in the latter years. It is essential for stakeholders to monitor these fluctuations closely to assess the company's effectiveness in generating profits relative to its total assets.
Peer comparison
Dec 31, 2024